参考文献/References:
[1] 胡铭洋,吴绮楠,吴永忠.肝癌的靶向和免疫治疗[J]. 重庆医科大学学报,2019,44(12):1547-1552.
[2] 马婧,王霄,宋争放,等.肝癌AASLD、EASL、JSH 指南及中国诊疗规范的比较[J]. 肿瘤的预防与治疗,2019,32(11):1031-1038.
[3] Gory I,Fink M,Bell S,et al. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study[J]. Scand J Gastroenterol,2015,50(5): 567-576.
[4] Maucort-Boulch D,de MC C,Franceschi S,et al. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide[J]. Int J Cancer,2018,142(12):2471-2477.
[5] Hua C,Bei S,Wang S,et al. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB[J]. Journal of Cancer Research & Clinical Oncology, 2010, 136(6):897-903.
[6] 严峻,文静,陈海南,等.二氢青蒿素联合替莫唑胺抑制胶质瘤细胞增殖和诱导凋亡[J]. 中华实验外科杂志,2019,36(2):274-276.
[7] Lee D H, Hasanuzzaman M, Kwon D, et al. 10-phenyltriazoyl artemisinin is a novel p-glycoprotein inhibitor that suppresses the overexpression and function of P-glycoprotein[J]. Curr Pharm Des, 2018, 24: 5590-5597.
[8] 曹鹏,冷东瑾,李滢,等.双氢青蒿素抗肿瘤分子生物学机制研究进展[J]. 浙江大学学报:医学版,2016,45(5):501-507.
[9] 郑鹏生,冀静.mTOR 信号通路与肿瘤的研究进展[J]. 西安交通大学学报:医学版,2010,31(1):5-9.
相似文献/References:
[1]李业森.68Ga标记TMTP1探针在肝癌肿瘤模型中的microPET/CT显像研究[J].福建医药杂志,2022,44(05):122.
Li Yesen.Study on microPET/CT imaging of 68GA-labeled TMTP1 probe in HCC tumor model[J].FUJIAN MEDICAL JOURNAL,2022,44(04):122.
[2]吴嘉旭,胡明超,王强,等.NDC1基因在肝癌中的诊断及预后价值的生物信息学分析[J].福建医药杂志,2023,45(01):7.
WU Jiaxu,HU Mingchao,WANG Qiang,et al.Bioinformatics analysis of the diagnostic and prognostic value of NDC1 gene in liver hepatocellular carcinoma[J].FUJIAN MEDICAL JOURNAL,2023,45(04):7.